Global Viral Vector Manufacturing Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1193

Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells.
Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.
In 2018, the global Viral Vector Manufacturing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Viral Vector Manufacturing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Vector Manufacturing development in United States, Europe and China.

The key players covered in this study
Cobra Biologics
Finvector
Merck
Novasep
Oxford BioMedica
Fujifilm Diosynth Biotechnologies
Sanofi
Spark Therapeutics
Kaneka Corporation (Eurogentec)
Thermo Fisher Scientific

Market segment by Type, the product can be split into
Adenoviral Vectors
Adeno-associated Viral Vectors
Retroviral Vectors
Lentiviral Vectors
Other

Market segment by Application, split into
Gene Therapy
Vaccinology

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Viral Vector Manufacturing status, future forecast, growth opportunity, key market and key players.
To present the Viral Vector Manufacturing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Viral Vector Manufacturing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Viral Vector Manufacturing Market Size Growth Rate by Type (2014-2025)
1.4.2 Adenoviral Vectors
1.4.3 Adeno-associated Viral Vectors
1.4.4 Retroviral Vectors
1.4.5 Lentiviral Vectors
1.4.6 Other
1.5 Market by Application
1.5.1 Global Viral Vector Manufacturing Market Share by Application (2014-2025)
1.5.2 Gene Therapy
1.5.3 Vaccinology
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Viral Vector Manufacturing Market Size
2.2 Viral Vector Manufacturing Growth Trends by Regions
2.2.1 Viral Vector Manufacturing Market Size by Regions (2014-2025)
2.2.2 Viral Vector Manufacturing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Viral Vector Manufacturing Market Size by Manufacturers
3.1.1 Global Viral Vector Manufacturing Revenue by Manufacturers (2014-2019)
3.1.2 Global Viral Vector Manufacturing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2 Viral Vector Manufacturing Key Players Head office and Area Served
3.3 Key Players Viral Vector Manufacturing Product/Solution/Service
3.4 Date of Enter into Viral Vector Manufacturing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Viral Vector Manufacturing Market Size by Type (2014-2019)
4.2 Global Viral Vector Manufacturing Market Size by Application (2014-2019)

5 United States
5.1 United States Viral Vector Manufacturing Market Size (2014-2019)
5.2 Viral Vector Manufacturing Key Players in United States
5.3 United States Viral Vector Manufacturing Market Size by Type
5.4 United States Viral Vector Manufacturing Market Size by Application

6 Europe
6.1 Europe Viral Vector Manufacturing Market Size (2014-2019)
6.2 Viral Vector Manufacturing Key Players in Europe
6.3 Europe Viral Vector Manufacturing Market Size by Type
6.4 Europe Viral Vector Manufacturing Market Size by Application

7 China
7.1 China Viral Vector Manufacturing Market Size (2014-2019)
7.2 Viral Vector Manufacturing Key Players in China
7.3 China Viral Vector Manufacturing Market Size by Type
7.4 China Viral Vector Manufacturing Market Size by Application

8 Japan
8.1 Japan Viral Vector Manufacturing Market Size (2014-2019)
8.2 Viral Vector Manufacturing Key Players in Japan
8.3 Japan Viral Vector Manufacturing Market Size by Type
8.4 Japan Viral Vector Manufacturing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Viral Vector Manufacturing Market Size (2014-2019)
9.2 Viral Vector Manufacturing Key Players in Southeast Asia
9.3 Southeast Asia Viral Vector Manufacturing Market Size by Type
9.4 Southeast Asia Viral Vector Manufacturing Market Size by Application

10 India
10.1 India Viral Vector Manufacturing Market Size (2014-2019)
10.2 Viral Vector Manufacturing Key Players in India
10.3 India Viral Vector Manufacturing Market Size by Type
10.4 India Viral Vector Manufacturing Market Size by Application

11 Central & South America
11.1 Central & South America Viral Vector Manufacturing Market Size (2014-2019)
11.2 Viral Vector Manufacturing Key Players in Central & South America
11.3 Central & South America Viral Vector Manufacturing Market Size by Type
11.4 Central & South America Viral Vector Manufacturing Market Size by Application

12 International Players Profiles
12.1 Cobra Biologics
12.1.1 Cobra Biologics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Viral Vector Manufacturing Introduction
12.1.4 Cobra Biologics Revenue in Viral Vector Manufacturing Business (2014-2019)
12.1.5 Cobra Biologics Recent Development
12.2 Finvector
12.2.1 Finvector Company Details
12.2.2 Company Description and Business Overview
12.2.3 Viral Vector Manufacturing Introduction
12.2.4 Finvector Revenue in Viral Vector Manufacturing Business (2014-2019)
12.2.5 Finvector Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Viral Vector Manufacturing Introduction
12.3.4 Merck Revenue in Viral Vector Manufacturing Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Novasep
12.4.1 Novasep Company Details
12.4.2 Company Description and Business Overview
12.4.3 Viral Vector Manufacturing Introduction
12.4.4 Novasep Revenue in Viral Vector Manufacturing Business (2014-2019)
12.4.5 Novasep Recent Development
12.5 Oxford BioMedica
12.5.1 Oxford BioMedica Company Details
12.5.2 Company Description and Business Overview
12.5.3 Viral Vector Manufacturing Introduction
12.5.4 Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2014-2019)
12.5.5 Oxford BioMedica Recent Development
12.6 Fujifilm Diosynth Biotechnologies
12.6.1 Fujifilm Diosynth Biotechnologies Company Details
12.6.2 Company Description and Business Overview
12.6.3 Viral Vector Manufacturing Introduction
12.6.4 Fujifilm Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2014-2019)
12.6.5 Fujifilm Diosynth Biotechnologies Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Viral Vector Manufacturing Introduction
12.7.4 Sanofi Revenue in Viral Vector Manufacturing Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Spark Therapeutics
12.8.1 Spark Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Viral Vector Manufacturing Introduction
12.8.4 Spark Therapeutics Revenue in Viral Vector Manufacturing Business (2014-2019)
12.8.5 Spark Therapeutics Recent Development
12.9 Kaneka Corporation (Eurogentec)
12.9.1 Kaneka Corporation (Eurogentec) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Viral Vector Manufacturing Introduction
12.9.4 Kaneka Corporation (Eurogentec) Revenue in Viral Vector Manufacturing Business (2014-2019)
12.9.5 Kaneka Corporation (Eurogentec) Recent Development
12.10 Thermo Fisher Scientific
12.10.1 Thermo Fisher Scientific Company Details
12.10.2 Company Description and Business Overview
12.10.3 Viral Vector Manufacturing Introduction
12.10.4 Thermo Fisher Scientific Revenue in Viral Vector Manufacturing Business (2014-2019)
12.10.5 Thermo Fisher Scientific Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details